Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV versus oral iron for early post-transplant anaemia after kidney transplantation
ACTRN12608000186358Phase 3Recruiting
- Sponsor
- Princess Alexandra Hospital
- Start
- Nov 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in anaemia comparing Oral ferrous sulphate with Intravenous iron polymaltose (2 arms). Primary endpoint: Time to normalisation of haemoglobin post renal transplant. Started Nov 2007; status: recruiting.
02
Drugs
iron polymaltoseferrous sulfate
03
Conditions
anaemia
Beyond the preview
Go deeper on ACTRN12608000186358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000186358.